fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models

(2009) R. V. Dudhani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increased Antimicrobial Susceptibility Profiles among Polymyxin‐ResistantAcinetobacter baumanniiClinical Isolates

(2008) Rodrigo E. Mendes et al.   CLINICAL INFECTIOUS DISEASES

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study

(2008) Nikolaos Markou et al.   CLINICAL THERAPEUTICS

Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin

(2008) M. D. David et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme

(2008) Wing Yau et al.   JOURNAL OF INFECTION

Acinetobacter Infection

(2008) L. Silvia Munoz-Price et al.   NEW ENGLAND JOURNAL OF MEDICINE